» Authors » Bhaskara R Jasti

Bhaskara R Jasti

Explore the profile of Bhaskara R Jasti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 121
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dattani S, Li X, Lampa C, Barriscale A, Damadzadeh B, Lechuga-Ballesteros D, et al.
Pharmaceutics . 2025 Jan; 17(1). PMID: 39861769
Micelles, liposomes, and solid lipid nanoparticles (SLNs) are promising drug delivery vehicles; however, poor aqueous stability requires post-processing drying methods for maintaining long-term stability. The objective of this study was...
2.
Aldawod H, Patel A, Emara R, Liang D, Ho J, Amin T, et al.
Nat Commun . 2025 Jan; 16(1):686. PMID: 39848946
The opioid crisis, driven by synthetic opioids like fentanyl, demands innovative solutions. The opioid antidote naloxone has a short action ( ~ 1 hour), requiring repeated doses. To address this,...
3.
Fouad S, Badr T, Abdelbary A, Fadel M, Abdelmonem R, Jasti B, et al.
AAPS PharmSciTech . 2024 Oct; 25(7):237. PMID: 39384727
Cellulite (CLT) is one of the commonly known lipodystrophy syndromes affecting post-adolescent women worldwide. It is topographically characterized by an orange-peel, dimpled skin appearance hence, it is an unacceptable cosmetic...
4.
Elhabal S, Abdelaal N, Saeed Al-Zuhairy S, Elrefai M, Hamdan A, Khalifa M, et al.
Int J Nanomedicine . 2024 Apr; 19:3045-3070. PMID: 38559447
Background: Diabetes Mellitus is a multisystem chronic pandemic, wound inflammation, and healing are still major issues for diabetic patients who may suffer from ulcers, gangrene, and other wounds from uncontrolled...
5.
Elhabal S, Abdelaal N, Al-Zuhairy S, Elrefai M, Khalifa M, Khasawneh M, et al.
Int J Nanomedicine . 2024 Feb; 19:1163-1187. PMID: 38344440
Purpose: Improving the treatment of psoriasis is a serious challenge today. Psoriasis is an immune-mediated skin condition affecting 125 million people worldwide. It is commonly treated with cyclosporine-A (CsA) and...
6.
Raparla S, Lampa C, Li X, Jasti B
Drug Dev Ind Pharm . 2024 Feb; 50(3):236-247. PMID: 38318700
Context: Determining solubility of drugs is laborious and time-consuming process that may not yield meaningful results. Amorphous solid dispersion (ASD) is a widely used solubility enhancement technique. Predictive models could...
7.
Eldougdoug M, Youssef D, El-Shal A, Sharaf Y, Raparla S, Jasti B, et al.
Eur J Pediatr . 2023 Jul; 182(10):4407-4420. PMID: 37486410
This study aimed to evaluate ceftriaxone pharmacokinetics that affects the achievement of targets in the treatment of critically ill children (meningitis, pneumonia, urinary tract infection, peritonitis, and infective endocarditis( who...
8.
Soliman S, Teaima M, Rashwan K, Ali B, Jasti B, El-Nabarawi M, et al.
Int J Pharm . 2022 Dec; 631:122525. PMID: 36549402
Pain and inflammation could have a negative impact on a patient's quality of life and performance, causing them to sleep less. Dexketoprofen trometamol (DKT) is a water-soluble, nonselective NSAIDs. Because...
9.
Dattani S, Li X, Lampa C, Lechuga-Ballesteros D, Barriscale A, Damadzadeh B, et al.
Int J Pharm . 2022 Dec; 631:122464. PMID: 36464111
The purpose of this work was to compare the in vitro and in vivo characteristics of LDV-targeted lipid-based micelles, liposomes and solid lipid nanoparticles (SLN) to provide further insights into...
10.
Abdelmonem R, Ibrahim Al-Samadi I, El Nashar R, Jasti B, El-Nabarawi M
Drug Deliv . 2022 Sep; 29(1):2868-2882. PMID: 36065090
Loratadine (LORA), is a topical antihistamine utilized in the treatment of ocular symptoms of COVID-19. The study aimed to develop a Loratadine Nanostructured Lipid Carriers Ocugel (LORA-NLCs Ocugel), enhance its...